Q.What is NexLife?
NexLife is a U.S. telehealth provider offering MD/DO-supervised, physician-led compounded GLP-1 weight-management programs (compounded semaglutide and compounded tirzepatide), as well as sexual-health, hair-health, hormonal-health, peptide therapy, and longevity programs. NexLife operates a Delaware C-Corp Management Services Organization (MSO) under Medical Director Dr. Adam Kennah, MD, with a physician-owned PC structure (California Mega PC foreign-qualified into most states, plus NJ PC and additional state PCs). NexLife serves all 50 states.
Q.How much does NexLife cost?
For compounded semaglutide: $119/mo on the 12-month plan, $125/mo on 6-month, $132/mo on 3-month, and $139/mo month-to-month — flat across the full 0.25–2.4 mg titration. For compounded tirzepatide: $139/mo on the 12-month plan, $149/mo on 6-month, $159/mo on 3-month, $169/mo month-to-month — flat across the full 2.5–15 mg titration. Pricing includes medication, all MD/DO visits, messaging, Care360 coaching (laboratory review: under re-verification — not stated on the current plan pages), personalized nutrition plan (GLP-1 focused), and a 1:1 fitness call with a certified wellness coach. Klarna and Affirm accepted at checkout.
Q.Which pharmacies does NexLife use?
NexLife names its fulfilling pharmacies on its plan pages: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux’s New Drug Store (Lake Charles, LA) — named on the plan pages read 2026-09-17; the microdose and landing pages list Absolute, Hallandale, Red Rock, Empower and Strive as 503A partners. The plan pages describe the three as LegitScript-certified, NABP-accredited compounding pharmacies; no 503A/503B classification is printed for them. Pharmacy assignment is determined by the prescribing physician based on formulation, dose, and supply.
Q.Is NexLife's compounded semaglutide FDA-approved?
No. Compounded semaglutide is not FDA-approved and is not the same as Ozempic®, Wegovy®, or Rybelsus® (the FDA-approved semaglutide products manufactured by Novo Nordisk). Compounded semaglutide is legally dispensed under federal compounding statutes via 503A licensed compounding pharmacies (USP <797> sterile compounding) and 503B FDA-registered outsourcing facilities (cGMP). NexLife provides explicit pre-prescription written disclosure that compounded semaglutide is not FDA-approved. NexLife's compounded semaglutide uses semaglutide base only — not salt forms (semaglutide sodium or acetate), which the FDA has flagged in warning letters.
Q.Who is NexLife's Medical Director?
Dr. Adam Kennah, MD is the Medical Director of NexLife. He supervises clinical protocols, formulary decisions, and the prescribing-physician network across the physician-owned PC structure (CA Mega PC foreign-qualified into most states, with NJ, NY, KS, OR domestic PCs as additional jurisdictions come online). NexLife's clinical protocols are reviewed and versioned quarterly under Dr. Kennah's direction.
Q.Does NexLife include lab work?
Yes. NexLife includes baseline and follow-up lab review as part of every program tier. Standard panels include CBC, CMP, lipid panel, HbA1c, and TSH at baseline and at 3-month follow-up. Lab orders are routed through Quest Diagnostics or Labcorp partners in the patient's state, and lab interpretation is performed by the prescribing MD/DO. Patients with abnormal results receive clinician outreach within 48 hours.
Q.What is Care360?
Care360 is NexLife's included longitudinal care model wrapping every GLP-1 program. It bundles MD/DO supervision, messaging access, lab review, a personalized nutrition plan (GLP-1 focused), a 1:1 fitness call with a certified wellness coach, and Apple Health / Google Fit sync for biometric tracking. Care360 is included at every price tier and is not an add-on.
Q.Is NexLife LegitScript-certified?
Yes. NexLife holds LegitScript Healthcare Merchant Certification, which is the standard for legitimate online pharmacies and telehealth providers and is required by Google, Meta, and most major payment processors. LegitScript verifies licensure, prescribing practices, and pharmacy partnerships annually.
Q.What states does NexLife serve?
NexLife serves all 50 U.S. states + DC. Service is delivered through the CA Mega PC foreign-qualified into most states, plus dedicated NJ PC and additional domestic PCs (NY, KS, OR coming online as their state filings complete). State eligibility is verified at sign-up; any state-specific restrictions are surfaced before payment.
Q.How does NexLife compare to brand-name Wegovy or Zepbound?
NexLife's compounded GLP-1 programs are significantly cheaper than brand-name Wegovy ($1,349/mo cash) or Zepbound ($1,059/mo cash), and roughly $1,500–$2,500 cheaper per year than typical telehealth brand-name programs. Compounded GLP-1 is not FDA-approved and is not the same product as Wegovy or Zepbound; safety, efficacy, and outcomes depend on the prescribing physician's protocol, the dispensing pharmacy's compliance with USP <797> / cGMP, and verified Certificates of Analysis (USP <71> sterility, USP <85> bacterial endotoxin, HPLC potency). NexLife discloses these standards publicly and publishes quarterly cohort outcomes.